We are in the midst of a paradigm shift in how cancer can be diagnosed and treated. The combination of targeted therapies and precise diagnostics is allowing for the era of personalized medicine to emerge. The capture and enrichment of circulating tumor cells is going to be a critical element of targeted companion diagnostics. We believe our next generation CTC capture system will allow the full diagnostic potential of CTCs to finally be realized.
Chairman of the Board
CEO & Board Member
CSO & VP R&D
Legal, Secretary & Board Member
Vortex Biosciences Inc, is a core subsidiary of NetScientific plc, a transatlantic biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at http://www.netscientific.net
Openings may be available in other areas as the company expands. So, if you are interested in an entrepreneurial role with opportunity for growth, if you are passionate about new technologies for improving overall health, if you want to be a part of unlocking the challenges of early cancer detection, we encourage you to contact us.
For more information or to apply, fill out the form provided or email us at firstname.lastname@example.org.